Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Combining microfluidics with machine learning algorithms for RBC classification in rare hereditary hemolytic anemia

  • Rizzuto, Valeria
  • Mencattini, Arianna
  • Álvarez-González, Begoña
  • Giuseppe, Davide di
  • Martinelli, Eugenio
  • Beneitez-Pastor, David
  • Mañú-Pereira, Maria del Mar
  • López Martínez, María José
  • Samitier i Martí, Josep
Combining microfuidics technology with machine learning represents an innovative approach to conduct massive quantitative cell behavior study and implement smart decision-making systems in support of clinical diagnostics. The spleen plays a key-role in rare hereditary hemolytic anemia (RHHA), being the organ responsible for the premature removal of defective red blood cells (RBCs). The goal is to adapt the physiological spleen fltering strategy for in vitro study and monitoring of blood diseases through RBCs shape analysis. Then, a microfuidic device mimicking the slits of the spleen red pulp area and video data analysis are combined for the characterization of RBCs in RHHA. This microfuidic unit is designed to evaluate RBC deformability by maintaining them fxed in planar orientation, allowing the visual inspection of RBC's capacity to restore their original shape after crossing microconstrictions. Then, two cooperative learning approaches are used for the analysis: the majority voting scheme, in which the most voted label for all the cell images is the class assigned to the entire video; and the maximum sum of scores to decide the maximally scored class to assign. The proposed platform shows the capability to discriminate healthy controls and patients with an average efciency of 91%, but also to distinguish between RHHA subtypes, with an efciency of 82%.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Versatile Vessel-on-a-Chip Platform for Studying Key Features of Blood Vascular Tumors

  • Llenas, Marina
  • Paoli, Roberto
  • Feiner Gràcia, Natalia
  • Albertazzi, Lorenzo
  • Samitier i Martí, Josep
  • Caballero Vila, David
Reproducció del document publicat a: https://doi.org/10.3390/bioengineering8060081, Tumor vessel-on-a-chip systems have attracted the interest of the cancer research community due to their ability to accurately recapitulate the multiple dynamic events of the metastatic cascade. Vessel-on-a-chip microfluidic platforms have been less utilized for investigating the distinctive features and functional heterogeneities of tumor-derived vascular networks. In particular, vascular tumors are characterized by the massive formation of thrombi and severe bleeding, a rare and life-threatening situation for which there are yet no clear therapeutic guidelines. This is mainly due to the lack of technological platforms capable of reproducing these characteristic traits of the pathology in a simple and well-controlled manner. Herein, we report the fabrication of a versatile tumor vessel-on-a-chip platform to reproduce, investigate, and characterize the massive formation of thrombi and hemorrhage on-chip in a fast and easy manner. Despite its simplicity, this method offers multiple advantages to recapitulate the pathophysiological events of vascular tumors, and therefore, may find useful applications in the field of vascular-related diseases, while at the same time being an alternative to more complex approaches., The authors acknowledge the support of CERCA Programme/Generalitat de Catalunya and the ICTS “NANBIOSIS” Nanotechnology Platform Unit of the CIBER in Bioengineering, Biomaterials & Nanomedicine (CIBER-BBN) at the Institute for Bioengineering of Catalonia for assistance in the microfabrication. M. Funes, D. Izquierdo, S. Blackburn, and M. de Pablo (Nanobioengineering group—IBEC) are acknowledged for technical support.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Combining microfluidics with machine learning algorithms for RBC classification in rare hereditary hemolytic anemia

  • Rizzuto, Valeria
  • Mencattini, Arianna
  • Álvarez-González, Begoña
  • Giuseppe, Davide di
  • Martinelli, Eugenio
  • Beneitez-Pastor, David
  • Mañú-Pereira, Maria del Mar
  • López Martínez, María José
  • Samitier i Martí, Josep
Combining microfuidics technology with machine learning represents an innovative approach to conduct massive quantitative cell behavior study and implement smart decision-making systems in support of clinical diagnostics. The spleen plays a key-role in rare hereditary hemolytic anemia (RHHA), being the organ responsible for the premature removal of defective red blood cells (RBCs). The goal is to adapt the physiological spleen fltering strategy for in vitro study and monitoring of blood diseases through RBCs shape analysis. Then, a microfuidic device mimicking the slits of the spleen red pulp area and video data analysis are combined for the characterization of RBCs in RHHA. This microfuidic unit is designed to evaluate RBC deformability by maintaining them fxed in planar orientation, allowing the visual inspection of RBC's capacity to restore their original shape after crossing microconstrictions. Then, two cooperative learning approaches are used for the analysis: the majority voting scheme, in which the most voted label for all the cell images is the class assigned to the entire video; and the maximum sum of scores to decide the maximally scored class to assign. The proposed platform shows the capability to discriminate healthy controls and patients with an average efciency of 91%, but also to distinguish between RHHA subtypes, with an efciency of 82%.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Versatile Vessel-on-a-Chip Platform for Studying Key Features of Blood Vascular Tumors

  • Llenas, Marina
  • Paoli, Roberto
  • Feiner Gràcia, Natalia
  • Albertazzi, Lorenzo
  • Samitier i Martí, Josep
  • Caballero Vila, David
Reproducció del document publicat a: https://doi.org/10.3390/bioengineering8060081, Tumor vessel-on-a-chip systems have attracted the interest of the cancer research community due to their ability to accurately recapitulate the multiple dynamic events of the metastatic cascade. Vessel-on-a-chip microfluidic platforms have been less utilized for investigating the distinctive features and functional heterogeneities of tumor-derived vascular networks. In particular, vascular tumors are characterized by the massive formation of thrombi and severe bleeding, a rare and life-threatening situation for which there are yet no clear therapeutic guidelines. This is mainly due to the lack of technological platforms capable of reproducing these characteristic traits of the pathology in a simple and well-controlled manner. Herein, we report the fabrication of a versatile tumor vessel-on-a-chip platform to reproduce, investigate, and characterize the massive formation of thrombi and hemorrhage on-chip in a fast and easy manner. Despite its simplicity, this method offers multiple advantages to recapitulate the pathophysiological events of vascular tumors, and therefore, may find useful applications in the field of vascular-related diseases, while at the same time being an alternative to more complex approaches., The authors acknowledge the support of CERCA Programme/Generalitat de Catalunya and the ICTS “NANBIOSIS” Nanotechnology Platform Unit of the CIBER in Bioengineering, Biomaterials & Nanomedicine (CIBER-BBN) at the Institute for Bioengineering of Catalonia for assistance in the microfabrication. M. Funes, D. Izquierdo, S. Blackburn, and M. de Pablo (Nanobioengineering group—IBEC) are acknowledged for technical support.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Usefulness of NGS for Diagnosis of Dominant Beta-Thalassemia and Unstable Hemoglobinopathies in Five Clinical Cases

  • Rizzuto, Valeria
  • Koopmann, Tamara T.
  • Blanco Alvarez, Adoración
  • Tazón Vega, Bárbara
  • Díaz de Heredia Rubio, Maria Cristina
  • Mañu Pereira, M Mar
  • Beneitez Pastor, David
  • Velasco Puyó, Pablo
  • Idrizovic, Amira
Seqüenciació de nova generació; Trastorns d’anèmia rars; Hemoglobinopaties inestables, Next generation sequencing; Rare anemia disorders; Unstable hemoglobinopathies, Secuenciación de nueva generación; Trastornos raros de la anemia; Hemoglobinopatías inestables, Unstable hemoglobinopathies (UHs) are rare anemia disorders (RADs) characterized by abnormal hemoglobin (Hb) variants with decreased stability. UHs are therefore easily precipitating, causing hemolysis and, in some cases, leading to dominant beta-thalassemia (dBTHAL). The clinical picture of UHs is highly heterogeneous, inheritance pattern is dominant, instead of recessive as in more prevalent major Hb syndromes, and may occur de novo. Most cases of UHs are not detected by conventional testing, therefore diagnosis requires a high index of suspicion of the treating physician. Here, we highlight the importance of next generation sequencing (NGS) methodologies for the diagnosis of patients with dBTHAL and other less severe UH variants. We present five unrelated clinical cases referred with chronic hemolytic anemia, three of them with severe blood transfusion dependent anemia. Targeted NGS analysis was performed in three cases while whole exome sequencing (WES) analysis was performed in two cases. Five different UH variants were identified correlating with patients’ clinical manifestations. Four variants were related to the beta-globin gene (Hb Bristol—Alesha, Hb Debrousse, Hb Zunyi, and the novel Hb Mokum) meanwhile one case was caused by a mutation in the alpha-globin gene leading to Hb Evans. Inclusion of alpha and beta-globin genes in routine NGS approaches for RADs has to be considered to improve diagnosis’ efficiency of RAD due to UHs. Reducing misdiagnoses and underdiagnoses of UH variants, especially of the severe forms leading to dBTHAL would also facilitate the early start of intensive or curative treatments for these patients., This study was supported by funding from the authors’ institutions and the European Commission H2020-MSCA-ITN-2019, Grant Agreement N860436, “EVIDENCE.”
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Usefulness of NGS for Diagnosis of Dominant Beta-Thalassemia and Unstable Hemoglobinopathies in Five Clinical Cases

  • Rizzuto, Valeria|||0000-0003-4728-6977
  • Koopmann, Tamara T.|||0000-0001-7918-6634
  • Blanco, Adoración|||0000-0002-6816-6598
  • Tazón-Vega, Bárbara|||0000-0003-4513-5104
  • Idrizovic, Amira
  • Díaz de Heredia, Cristina|||0000-0001-8086-296X
  • Del Orbe Barreto, Rafael Andrés|||0000-0002-1240-1958
  • Pampliega, Miriam Vara|||0000-0002-4381-2784
  • Velasco Puyo, Pablo|||0000-0001-7331-9483
  • Beneitez Pastor, David|||0000-0002-6541-6600
  • Santen, Gijs Santen W.E.|||0000-0003-1959-3267
  • Waisfisz, Quinten|||0000-0002-7384-9182
  • Elting, Mariet
  • Smiers, Frans J.W.|||0000-0002-8131-3521
  • de Pagter, Anne J.|||0000-0002-7051-1872
  • Kerkhoffs, Jean Louis H.
  • Harteveld, Cornelis L.|||0000-0002-5135-6491
  • Mañú Pereira, María del Mar|||0000-0003-4770-7460
Unstable hemoglobinopathies (UHs) are rare anemia disorders (RADs) characterized by abnormal hemoglobin (Hb) variants with decreased stability. UHs are therefore easily precipitating, causing hemolysis and, in some cases, leading to dominant beta-thalassemia (dBTHAL). The clinical picture of UHs is highly heterogeneous, inheritance pattern is dominant, instead of recessive as in more prevalent major Hb syndromes, and may occur de novo. Most cases of UHs are not detected by conventional testing, therefore diagnosis requires a high index of suspicion of the treating physician. Here, we highlight the importance of next generation sequencing (NGS) methodologies for the diagnosis of patients with dBTHAL and other less severe UH variants. We present five unrelated clinical cases referred with chronic hemolytic anemia, three of them with severe blood transfusion dependent anemia. Targeted NGS analysis was performed in three cases while whole exome sequencing (WES) analysis was performed in two cases. Five different UH variants were identified correlating with patients' clinical manifestations. Four variants were related to the beta-globin gene (Hb Bristol-Alesha, Hb Debrousse, Hb Zunyi, and the novel Hb Mokum) meanwhile one case was caused by a mutation in the alpha-globin gene leading to Hb Evans. Inclusion of alpha and beta-globin genes in routine NGS approaches for RADs has to be considered to improve diagnosis' efficiency of RAD due to UHs. Reducing misdiagnoses and underdiagnoses of UH variants, especially of the severe forms leading to dBTHAL would also facilitate the early start of intensive or curative treatments for these patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Combining microfluidics with machine learning algorithms for RBC classification in rare hereditary hemolytic anemia

  • Rizzuto, Valeria|||0000-0003-4728-6977
  • Mencattini, Arianna
  • Álvarez-González, Begoña
  • Di Giuseppe, Davide
  • Beneitez Pastor, David|||0000-0002-6541-6600
  • Mañú Pereira, María del Mar|||0000-0003-4770-7460
  • Lopez-Martinez, Maria José
  • Samitier, Josep|||0000-0002-1140-3679
Combining microfluidics technology with machine learning represents an innovative approach to conduct massive quantitative cell behavior study and implement smart decision-making systems in support of clinical diagnostics. The spleen plays a key-role in rare hereditary hemolytic anemia (RHHA), being the organ responsible for the premature removal of defective red blood cells (RBCs). The goal is to adapt the physiological spleen filtering strategy for in vitro study and monitoring of blood diseases through RBCs shape analysis. Then, a microfluidic device mimicking the slits of the spleen red pulp area and video data analysis are combined for the characterization of RBCs in RHHA. This microfluidic unit is designed to evaluate RBC deformability by maintaining them fixed in planar orientation, allowing the visual inspection of RBC's capacity to restre their original shape after crossing microconstrictions. Then, two cooperative learning approaches are used for the analysis: the majority voting scheme, in which the most voted label for all the cell images is the class assigned to the entire video; and the maximum sum of scores to decide the maximally scored class to assign. The proposed platform shows the capability to discriminate healthy controls and patients with an average efficiency of 91%, but also to distinguish between RHHA subtypes, with an efficiency of 82%.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Usefulness of NGS for Diagnosis of Dominant Beta-Thalassemia and Unstable Hemoglobinopathies in Five Clinical Cases

  • Rizzuto, Valeria
  • Koopmann, Tamara T.
  • Blanco Alvarez, Adoración
  • Tazón Vega, Bárbara
  • Díaz de Heredia Rubio, Maria Cristina
  • Mañu Pereira, M Mar
  • Beneitez Pastor, David
  • Velasco Puyó, Pablo
  • Idrizovic, Amira
Seqüenciació de nova generació; Trastorns d’anèmia rars; Hemoglobinopaties inestables, Next generation sequencing; Rare anemia disorders; Unstable hemoglobinopathies, Secuenciación de nueva generación; Trastornos raros de la anemia; Hemoglobinopatías inestables, Unstable hemoglobinopathies (UHs) are rare anemia disorders (RADs) characterized by abnormal hemoglobin (Hb) variants with decreased stability. UHs are therefore easily precipitating, causing hemolysis and, in some cases, leading to dominant beta-thalassemia (dBTHAL). The clinical picture of UHs is highly heterogeneous, inheritance pattern is dominant, instead of recessive as in more prevalent major Hb syndromes, and may occur de novo. Most cases of UHs are not detected by conventional testing, therefore diagnosis requires a high index of suspicion of the treating physician. Here, we highlight the importance of next generation sequencing (NGS) methodologies for the diagnosis of patients with dBTHAL and other less severe UH variants. We present five unrelated clinical cases referred with chronic hemolytic anemia, three of them with severe blood transfusion dependent anemia. Targeted NGS analysis was performed in three cases while whole exome sequencing (WES) analysis was performed in two cases. Five different UH variants were identified correlating with patients’ clinical manifestations. Four variants were related to the beta-globin gene (Hb Bristol—Alesha, Hb Debrousse, Hb Zunyi, and the novel Hb Mokum) meanwhile one case was caused by a mutation in the alpha-globin gene leading to Hb Evans. Inclusion of alpha and beta-globin genes in routine NGS approaches for RADs has to be considered to improve diagnosis’ efficiency of RAD due to UHs. Reducing misdiagnoses and underdiagnoses of UH variants, especially of the severe forms leading to dBTHAL would also facilitate the early start of intensive or curative treatments for these patients., This study was supported by funding from the authors’ institutions and the European Commission H2020-MSCA-ITN-2019, Grant Agreement N860436, “EVIDENCE.”